Zacks Research Issues Positive Forecast for PCRX Earnings
Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) – Equities researchers at Zacks Research upped their Q3 2025 earnings estimates for Pacira BioSciences in a report issued on Thursday, May 29th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $0.44 for the quarter, up from their prior forecast […]
